
Theotrax SB 500mg/250mg Injection
Marketer
Theogen Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Theotrax SB 500mg/250mg Injection
Combiflox 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and spread. Administration must be solely under medical supervision; strict adherence to the prescribed dosage schedule is crucial, even with symptom improvement, to ensure therapeutic efficacy. Abrupt cessation may compromise treatment effectiveness. Common side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical consultation. Seek emergency care for allergic reactions (skin rashes, pruritus, edema, respiratory distress). Inform your physician of all current medications, particularly if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing somnolence or dizziness. Adequate rest, a nutritious diet, and sufficient hydration will promote faster recovery. Your doctor might request laboratory tests to monitor treatment response.
Primary Ingredients of Theotrax SB 500mg/250mg Injection
No text provided to rephrase.
Uses of Theotrax SB 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Theotrax SB 500mg/250mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of Theotrax SB 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Theotrax SB 500mg/250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Theotrax SB 500mg/250mg Injection works:
Ceftriaxone and sulbactam, combined as Theotrax SB 500mg/250mg Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam's role as a beta-lactamase inhibitor counters bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Theotrax SB 500mg/250mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Administration of Theotrax SB 500mg/250mg Injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Theotrax SB 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Theotrax SB 500mg/250mg Injection may induce drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Theotrax SB 500mg/250mg Injection's use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Theotrax SB 500mg/250mg Injection cautiously, potentially requiring dosage modification. Mild to moderate liver dysfunction does not necessitate a Theotrax SB 500mg/250mg Injection dose adjustment; however, physician consultation is advised in all cases.
What if you forget to take Theotrax SB 500mg/250mg Injection :
Omitting a scheduled dose of Theotrax SB 500mg/250mg Injection necessitates contacting your physician.
Facts to Know About Theotrax SB 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
